BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Aerobiotix

1 post

Aerobiotix is a leader in air quality management solutions for healthcare, assisted living, and education. Its medical-grade items utilize ultraviolet light, HEPA filters, and special filtration to eliminate 99.9 percent of germs, viruses, VOCs, and other pollutants.

The air quality management technology is quiet, safe, and intended to operate continuously in occupied rooms to reduce the risk of infections while also enhancing environmental safety. Aerobiotix solutions include monitoring systems that help facilities around the world measure and manage air quality.

Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital

Biotech NewsAerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital

  • BioTech Health X
  • May 6, 2021
Aerobiotix, a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Insmed (INSM) Jumps to $149.20 High After FDA Approval of Brinsupri
  • Ocular Therapeutix (OCUL) Raises $475M to Fund Phase 3 Axpaxli Trials
  • Novavax (NVAX) Expands $200M Sanofi Deal With Matrix-M Adjuvant
  • Recursion Pharmaceuticals (RXRX) Could Double With $8 Price Target
  • Dermata (DRMA) Wins Australian Patent for Acne Therapy
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 3, 2025
    Insmed (INSM) Jumps to $149.20 High After FDA Approval of Brinsupri
    • October 3, 2025
    Ocular Therapeutix (OCUL) Raises $475M to Fund Phase 3 Axpaxli Trials
    • October 3, 2025
    Novavax (NVAX) Expands $200M Sanofi Deal With Matrix-M Adjuvant
    • October 3, 2025
    Recursion Pharmaceuticals (RXRX) Could Double With $8 Price Target
    • October 2, 2025
    Dermata (DRMA) Wins Australian Patent for Acne Therapy
Recent Posts
  • Kazia (KZIA) Trades Under $1 While Tackling Cancers With <1-Year Survival Rates
    • October 2, 2025
  • CorMedix (CRMD) Revenue to Hit $350M After Melinta Buyout
    • October 2, 2025
  • Halozyme (HALO) Reports $1.179B Revenue and 65% Royalty Growth
    • October 2, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (439)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top